Bioconjugates
and ADCs

Through a comprehensive technology transfer process, we deliver a successful scale-up model to ensure robust and consistent manufacturing process from clinical to commercial scale.

We collaborate with your team to de-risk the pathway to commercialization, ensure manufacturability, and deliver a quality medicine to the patient.

Our capabilities include:

• Sartorius Sartoflow^® Smart and Advance TFF systems for scale-up development and production in process development at volumes from 100mL – 50L and 0.1 – 2.1 m² membrane surface area allowing for straightforward transfer to cGMP manufacturing
• Sartorius Sartoflow^® Alpha Plus SU and FlexAct^® SU TFF systems for GMP manufacturing with volume ranges from 1 – 200L and up to 3.5 m^{2/sup> membrane surface area}
• Full complement of AKTA FPLC™ systems in process development including an AKTA Pilot FPLC skid in process development capable of batch purification of more than 250g of bioconjugates in a day
• AKTA Ready Gradient chromatography skid in GMP manufacturing suite capable of batch purification of greater than 1kg bioconjugate in a day
• Conjugation reaction stirring capabilities include rocking motion mixers of volumes up to 50L and Sartorius LevMixer® pallet tanks from 50 – 1000L volume capacity